85 results
8-K
EX-99.1
CVS
CVS Health Corp
5 Dec 23
CVS Health highlights path to accelerating long-term growth
6:31am
outlook, capital deployment strategy, and long-term outlook and growth targets. The company’s unique combination of assets provides CVS Health … to, references to CVS Health Corporation’s priority areas for strategic growth, financial outlook, long-term growth targets, capital deployment, Ms. Lynch’s
8-K
EX-99.1
CVS
CVS Health Corp
23 Aug 23
CVS Health Launches Cordavis
4:22pm
tissues. Hyrimoz targets and blocks the protein that contributes to disease symptoms.
INDICATIONS
HYRIMOZ® (adalimumab-adaz) is a tumor necrosis
S-8
EX-99.1
1vg51fup
2 Aug 23
Registration of securities for employees
4:31pm
8-K
EX-99.1
w2cib5iwm zh522km4cb
25 May 23
Other Events
6:30am
8-K
ygino2pj7ub8
30 Mar 23
Regulation FD Disclosure
7:46am
S-8
EX-99.1
m1urt2e6plp
29 Mar 23
Registration of securities for employees
4:12pm
DEFA14A
be5l789 sn8sy
6 Sep 22
Additional proxy soliciting materials
6:19am
8-K
EX-99.2
g07v hgq737r
6 Sep 22
CVS Health to Acquire Signify Health
6:17am
8-K
EX-99.1
afcro3w75 tmnwf80eg
9 Feb 22
Results of Operations and Financial Condition
6:33am
8-K
EX-99.1
4gxkg0d nw0wq0
9 Dec 21
CVS Health Presents Strategy for Revolutionizing Consumer Health Experience While Driving Profitable Growth
6:43am